-
Je něco špatně v tomto záznamu ?
The role of nitric oxide during embryonic wound healing
P. Abaffy, S. Tomankova, R. Naraine, M. Kubista, R. Sindelka,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
RVO: 86652036
Ministerstvo Školství, Mládeže a Tělovýchovy
CZ.1.05/1.1.00/02.0109
European Regional Development Fund
GA17-24441S
Grantová Agentura České Republiky
NLK
BioMedCentral
od 2000-12-01
BioMedCentral Open Access
od 2000
Directory of Open Access Journals
od 2000
Free Medical Journals
od 2000
PubMed Central
od 2000
Europe PubMed Central
od 2000 do 2020
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2000-07-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2000-01-01
Medline Complete (EBSCOhost)
od 2000-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
Springer Nature OA/Free Journals
od 2000-12-01
- MeSH
- embryo nesavčí cytologie metabolismus fyziologie MeSH
- glukosa metabolismus MeSH
- hojení ran * MeSH
- leptin metabolismus MeSH
- oxid dusnatý metabolismus MeSH
- regulace genové exprese MeSH
- signální transdukce MeSH
- Xenopus laevis MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The study of the mechanisms controlling wound healing is an attractive area within the field of biology, with it having a potentially significant impact on the health sector given the current medical burden associated with healing in the elderly population. Healing is a complex process and includes many steps that are regulated by coding and noncoding RNAs, proteins and other molecules. Nitric oxide (NO) is one of these small molecule regulators and its function has already been associated with inflammation and angiogenesis during adult healing. RESULTS: Our results showed that NO is also an essential component during embryonic scarless healing and acts via a previously unknown mechanism. NO is mainly produced during the early phase of healing and it is crucial for the expression of genes associated with healing. However, we also observed a late phase of healing, which occurs for several hours after wound closure and takes place under the epidermis and includes tissue remodelling that is dependent on NO. We also found that the NO is associated with multiple cellular metabolic pathways, in particularly the glucose metabolism pathway. This is particular noteworthy as the use of NO donors have already been found to be beneficial for the treatment of chronic healing defects (including those associated with diabetes) and it is possible that its mechanism of action follows those observed during embryonic wound healing. CONCLUSIONS: Our study describes a new role of NO during healing, which may potentially translate to improved therapeutic treatments, especially for individual suffering with problematic healing.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005722
- 003
- CZ-PrNML
- 005
- 20200518132038.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12864-019-6147-6 $2 doi
- 035 __
- $a (PubMed)31694542
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Abaffy, Pavel $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.
- 245 14
- $a The role of nitric oxide during embryonic wound healing / $c P. Abaffy, S. Tomankova, R. Naraine, M. Kubista, R. Sindelka,
- 520 9_
- $a BACKGROUND: The study of the mechanisms controlling wound healing is an attractive area within the field of biology, with it having a potentially significant impact on the health sector given the current medical burden associated with healing in the elderly population. Healing is a complex process and includes many steps that are regulated by coding and noncoding RNAs, proteins and other molecules. Nitric oxide (NO) is one of these small molecule regulators and its function has already been associated with inflammation and angiogenesis during adult healing. RESULTS: Our results showed that NO is also an essential component during embryonic scarless healing and acts via a previously unknown mechanism. NO is mainly produced during the early phase of healing and it is crucial for the expression of genes associated with healing. However, we also observed a late phase of healing, which occurs for several hours after wound closure and takes place under the epidermis and includes tissue remodelling that is dependent on NO. We also found that the NO is associated with multiple cellular metabolic pathways, in particularly the glucose metabolism pathway. This is particular noteworthy as the use of NO donors have already been found to be beneficial for the treatment of chronic healing defects (including those associated with diabetes) and it is possible that its mechanism of action follows those observed during embryonic wound healing. CONCLUSIONS: Our study describes a new role of NO during healing, which may potentially translate to improved therapeutic treatments, especially for individual suffering with problematic healing.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a embryo nesavčí $x cytologie $x metabolismus $x fyziologie $7 D004625
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a glukosa $x metabolismus $7 D005947
- 650 _2
- $a leptin $x metabolismus $7 D020738
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a signální transdukce $7 D015398
- 650 12
- $a hojení ran $7 D014945
- 650 _2
- $a Xenopus laevis $7 D014982
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tomankova, Silvie $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.
- 700 1_
- $a Naraine, Ravindra $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.
- 700 1_
- $a Kubista, Mikael $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic. TATAA Biocenter, Odinsgatan 28, 411 03, Göteborg, Sweden.
- 700 1_
- $a Sindelka, Radek $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic. sindelka@ibt.cas.cz.
- 773 0_
- $w MED00008181 $t BMC genomics $x 1471-2164 $g Roč. 20, č. 1 (2019), s. 815
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31694542 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200518132038 $b ABA008
- 999 __
- $a ok $b bmc $g 1524580 $s 1095778
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 20 $c 1 $d 815 $e 20191106 $i 1471-2164 $m BMC genomics $n BMC Genomics $x MED00008181
- GRA __
- $a RVO: 86652036 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a CZ.1.05/1.1.00/02.0109 $p European Regional Development Fund
- GRA __
- $a GA17-24441S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20200511